HomeFilePharmacology

Pharmacology

View Category

Coronary disease

The 10 most read articles of September

1- High-Sensitivity Troponins Turned All Events into Infarctions; the 4th Universal Definition Clarifies Things Myocardial infarction or myocardial...
solaci -
Learn More
Antithrombotic Anticoagulants

TCT 2018 | OAC-ALONE: Anticoagulation Alone 1 Year After Stenting in Patients with Atrial Fibrillation

Up to now, there had been no randomized controlled trial assessing oral anticoagulation alone vs. oral anticoagulation...
solaci -
Learn More
Pharmacology

What to Do with Blood Pressure Levels Between 130/80 and 139/89 mmHg

The decision to be made with a treatment-free patient with systolic blood pressure over 160 mmHg or diastolic...
solaci -
Learn More
Pharmacology

Ten Commandments of the European Hypertension Guidelines: Several “Sins Allowed” Compared with American Guidelines

These new hypertension guidelines (which were as long-awaited as the American ones, back then) finally emerged in...
solaci -
Learn More
Coronary disease

Relive the SOLACI-SOCIME 2018 Congress

Over 2180 professionals from all over the world gathered in Mexico City to continue developing interventional cardiology in...
solaci -
Learn More
Antiplatelet

Antiaggregation Time after Treating Bifurcations

Defining dual antiplatelet therapy (DAPT) seems a never-ending story. We go from trials showing the safety of...
solaci -
Learn More
Antiplatelet

ESC 2018 | GLOBAL LEADERS: Ticagrelor Monotherapy Is Not Superior to Classic Therapies After Angioplasty

Dropping aspirin after the first month and continuing with ticagrelor monotherapy was not better than standard dual...
solaci -
Learn More
Antiplatelet

ESC 2018 | ARRIVE: Aspirin in the Eye of the Storm of Primary Prevention

Aspirin failed to reach the primary endpoint in a population that was at risk of experiencing cardiovascular...
solaci -
Learn More